Skin Care Research is currently enrolling participants for an Androgenetic Alopecia clinical trial in Hollywood, FL. Qualified participants will receive all study-related care provided by board-certified dermatologists at one of our partnered clinics. All Skin Care Research studies are in compliance with FDA guidelines and uphold the highest clinical standards.
To Qualify:
- Must be 18 – 65 years old
- Must have mild to moderate male pattern baldness
- Study location in Hollywood, FL
To learn more, fill out a form on this page or call 561-948-3116
*NO COST. NO INSURANCE. MAY QUALIFY FOR COMPENSATION.*
Androgenetic Alopecia Clinical Trials: What is Androgenetic Alopecia?
Androgenetic alopecia is a common form of hair loss caused by a combination of genetics and hormones. It occurs when hair follicles are affected by dihydrotestosterone (DHT), a hormone that shrinks the follicles and shortens the hair growth cycle. Over time, this leads to thinner, weaker hairs and eventually a reduction in hair density. It is more common in adults and progresses gradually over time.
In men, androgenetic alopecia typically begins with a receding hairline or thinning at the crown, often forming an “M” shape before progressing to more extensive baldness. In women, it usually appears as widespread thinning across the scalp, especially along the part, without a significant change in the hairline. Although it cannot be completely cured, treatments such as minoxidil, finasteride (for men), low-level laser therapy, or hair transplants can help slow hair loss and, in some cases, stimulate regrowth.
About Skin Care Research
As a clinical research center with over 25 years of experience in the execution of dermatological and cosmetic clinical trials, Skin Care Research has conducted hundreds of successful research studies for trusted brands including Abbvie, Eli Lilly, Galderma, Pfizer Inc, and more. Our research staff and board-certified dermatologists are highly trained and experienced in conducting FDA approved clinical trials.
Skin Care Research conducts phase 2 through phase 4 clinical trials with patient safety being the number one priority. To learn more about our enrolling studies, including time commitment, participant responsibilities, and other things you should expect, fill out the form or give us a call at 561-948-3116.
